-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CAFvjpCCXG+uU3urGr96em6byRiP90r42/ay6lHKurzz81HxWa6p0pl/VfBjweE5 DGpRwkUdvq8SJ8oXY/njlw== 0001140361-07-014668.txt : 20070725 0001140361-07-014668.hdr.sgml : 20070725 20070725133935 ACCESSION NUMBER: 0001140361-07-014668 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070724 FILED AS OF DATE: 20070725 DATE AS OF CHANGE: 20070725 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5105741400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iwanicki David CENTRAL INDEX KEY: 0001322481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 07998951 BUSINESS ADDRESS: BUSINESS PHONE: 510-574-1400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DRIVE CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc1.xml FORM 4 X0202 4 2007-07-24 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001322481 Iwanicki David C/O PDL BIOPHARMA, INC. 34801 CAMPUS DRIVE FREMONT CA 94555 0 1 0 0 VP, Sales & Sales Operations Common Stock 2007-07-24 4 M 0 2187 15.73 A 2187 D Common Stock 2007-07-24 4 S 0 200 25.02 D 1987 D Common Stock 2007-07-24 4 S 0 200 25.06 D 1787 D Common Stock 2007-07-24 4 S 0 210 25.15 D 1577 D Common Stock 2007-07-24 4 S 0 210 25.17 D 1367 D Common Stock 2007-07-24 4 S 0 210 25.23 D 1157 D Common Stock 2007-07-24 4 S 0 210 25.53 D 947 D Common Stock 2007-07-24 4 S 0 250 25.14 D 697 D Common Stock 2007-07-24 4 S 0 697 25.20 D 0 D Employee Stock Option (Right to Buy) 15.73 2007-07-24 4 M 0 2187 0 D 2015-04-18 Common Stock 2187 43758 D Sale was made pursuant to a 10b5-1 plan established by the reporting person. Option vests with respect to 2,187.5 shares per month and 8 shares remained exercisable immediately after this transaction. Only vested options are exercisable /s/ Francis Sarena by Francis Sarena, Attorney- in- Fact for David Iwanicki 2007-07-27 -----END PRIVACY-ENHANCED MESSAGE-----